These findings suggest that miR-632 and DNAJB6 can be important biomarkers for metastatic and malignant progression of breast cancer and that targeting miR-632 may provide novel strategies for inhibiting cancer metastasis [33]. The gene discussed is DNAJB6; the disease is breast cancer.